Nicolini H

Language: Spanish
References: 12
Page: 79-80
PDF size: 35.39 Kb.

Text Extraction

No abstract

REFERENCES

1. Desjarlais RR. World mental health: problems and priorities in low-income countries. New York: Oxford University Press; 1995.

2. Frenk-Mora J. Alucinaciones, delirio y paranoia, síntomas de esquizofrenia. Comunicado de Prensa 341, Secretaría de Salud, México; 2005.

3. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, et al. Schizophrenia manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med 1992;22:1.

4. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005;66:1122-1129.

5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth edition. Washington, DC: American Psychiatric Association; 2000.

6. Serretti A, Mandelli L, Bajo E, Cevenini N, Papili P, Mori E, et al. The socioeconomical burden of schizophrenia: A simulation of cost-offset of early intervention program in Italy. Eur Psychiatry 2009;24:11-16.

7. Ramírez-Bermúdez J, Soto-Hernández JL, López-Gómez M, Mendoza-Silva M, Colín-Piana R, Campillo-Serrano C. Frequency of neuropsychiatric signs and symptoms in patients with viral encephalitis. Rev Neurol 2005;41:140-144.

8. Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149:1183-1188.

9. Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008;65:28-37.

10. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M, et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res 2003;60:21-32.

11. Menon M, Jensen J, Vitcu I, Graff-Guerrero A, Crawley A, Smith MA, et al. Temporal difference modeling of the blood-oxygen level dependent response during aversive conditioning in humans: effects of dopaminergic modulation. Biol Psychiatry 2007;62:765-772.

12. De la Fuente-Sandoval C, Favila R, Alvarado P, León-Ortiz P, Díaz-Galvis L, Amezcua C, et al. Incremento del glutamato en el estriado de asociación en esquizofrenia: estudio longitudinal con espectroscopia por resonancia magnética. Gac Med Mex 2009;146:109-113.